Article
Antisense Inhibition of Prekallikrein to Control Hereditary Angioedema
2 Sept 2020
Abstract excerpt
at a dose of 80 mg every 3 to 4 weeks for 7 to 8 months. Treatment was accompanied by a reduction in the angioedema attack rate. (Funded by Amsterdam UMC.).
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.